0 false false false false false false false false false false true false false false false true false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 05173265 2024-01-01 2024-12-31 05173265 2024-12-31 05173265 2023-12-31 05173265 2023-01-01 2023-12-31 05173265 2023-12-31 05173265 2022-12-31 05173265 bus:Director1 2024-01-01 2024-12-31 05173265 core:WithinOneYear 2024-12-31 05173265 core:WithinOneYear 2023-12-31 05173265 core:ShareCapital 2024-12-31 05173265 core:ShareCapital 2023-12-31 05173265 core:CapitalRedemptionReserve 2024-12-31 05173265 core:CapitalRedemptionReserve 2023-12-31 05173265 core:RetainedEarningsAccumulatedLosses 2024-12-31 05173265 core:RetainedEarningsAccumulatedLosses 2023-12-31 05173265 bus:SmallEntities 2024-01-01 2024-12-31 05173265 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 05173265 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05173265 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05173265 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 05173265

Home Heart Care Limited

Filleted Unaudited Financial Statements

31 December 2024

Home Heart Care Limited

Statement of Financial Position

31 December 2024

| 2024 | 2023
Note | £ | £ | £

Current assets

Cash at bank and in hand | 512 |  | 655

Creditors: amounts falling due within one year | 4 | 5,166 |  | 4,796
| ------- |  | -------
Net current liabilities |  | 4,654 | 4,141
|  | ------- | -------
Total assets less current liabilities |  | ( 4,654) | ( 4,141)
|  | ------- | -------
Net liabilities |  | ( 4,654) | ( 4,141)
|  | ------- | -------

Capital and reserves

Called up share capital |  | 8,002 | 8,002
Capital redemption reserve |  | 4,001 | 4,001
Profit and loss account |  | ( 16,657) | ( 16,144)
|  | -------- | --------
Shareholders deficit |  | ( 4,654) | ( 4,141)
|  | -------- | --------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 10 September 2025 , and are signed on behalf of the board by:

Mrs P McGurk |
Director |

Company registration number: 05173265

Home Heart Care Limited

Notes to the Financial Statements

Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is International House, 109-111 Fulham Palace Road, London, England, W6 8JA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
Deferred tax is provided in full on timing differences which result in an obligation at the balance sheet date to pay more tax, or a right to pay less tax, at a future date, at rates expected to apply when they crystallise based on current tax rates and law. Timing differences arise from the inclusion of items of income and expenditure in taxation computations in periods different from those in which they are included in the financial statements. Deferred tax assets are recognised to the extent that it it is regarded as more likely than not that they will be recovered. Deferred tax assets and liabilities are not discounted.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Creditors: amounts falling due within one year

| 2024 | 2023
| £ | £
Other creditors | 5,166 | 4,796
| ------- | -------

5. Director's advances, credits and guarantees
During the year the director advanced net loans to the company of £250 (2023: £685). The amount owed to the director at the year end is £4,926 (2023 : £4,676).
6. Related party transactions
No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 102.